FQHC Vision Care in 2026: Six Stories, Six Numbers, and Three Deadlines That Matter

The economics: six numbers worth memorizing

California FQHC vision care economics aren't subtle. The Prospective Payment System rate makes optometry visits among the most profitable service lines available to a community health center — yet 3 of 4 FQHCs nationally don't offer vision. Six numbers explain why this gap is the largest unmet revenue opportunity in the FQHC sector.

• $300+ — conservative California FQHC PPS encounter rate. Many established CA FQHCs run $400+. Each optometry visit qualifies for the FULL encounter rate under the DHCS APM Program Guide.
• $1.08M — annual PPS revenue from a single OD seeing 16 patients/day for 240 work days, at $300/encounter. ~$700K line margin at conservative cost assumptions. Run YOUR numbers in our ROI Calculator.
• $43.67 — 2025 Medicare reimbursement for CPT 92229 (autonomous AI imaging of retina). For comparison: CPT 92228 (MD interpretation) pays $29.14, CPT 92227 (staff review) pays $17.35. CMS deliberately rewards autonomous AI more than human work.
• $155,210 — average FQHC optometrist salary nationally per ACU 2023 FQHC Optometry Workforce Survey. Counter-intuitively: rural FQHC ODs earn $168K vs urban $151K — a $17K rural premium driven by recruitment scarcity.
• $47 — California Medi-Cal reimbursement per comprehensive eye exam, unchanged for 25 years. Only 10% of California Optometric Association members accept Medi-Cal at this rate. This is the structural reason commercial-practice ODs won't take Medi-Cal patients — and why FQHCs are the only realistic capacity vehicle.
• $630M — NACHC's proposed one-time investment to hire 1,070 optometrists serving 10.7 million currently unserved CHC patients. The federal advocacy anchor; the policy fight ahead.

The access crisis: who isn't getting eye care

Vision care disparities in California's safety-net population are documented, persistent, and worsening. The CalMatters story in April 2026 made the children's piece impossible to ignore, but the adult and farmworker pictures are equally stark.

Pediatric Medi-Cal: only 16% of California Medi-Cal kids in 2022-24 got an eye exam — down from 19% eight years earlier. 47 of 58 counties got worse. California Education Code §49455 mandates vision screening at K, grades 2, 5, and 8 — but the screening identifies need and the system can't deliver follow-up. Children fail their school screening, get a referral letter, and the referral dies because no provider in their network accepts Medi-Cal.

Latino adults: the Los Angeles Latino Eye Study (LALES) — the foundational NEI population-based study of 6,357 LA Latinos aged 40+ — established that ~50% of Latinos with diabetes have diabetic retinopathy, with >10% having macular edema. 75% of Latinos with open-angle glaucoma or ocular hypertension were UNDIAGNOSED before LALES screening. Most CA FQHCs serve the same population LALES studied. Most don't have routine glaucoma screening protocols built into primary care.

Black adults: 5-6× higher open-angle glaucoma prevalence and 6× the blindness rate vs white peers, with first diagnosis on average ~10 years earlier and disease progression 0.43 dB/year faster (Glaucoma Research Foundation). Standard age-40 screening is too late for Black patients; protocols should start at age 35.

AAPI adults: elevated angle-closure glaucoma risk due to anatomically shallower anterior chambers; up to 86% myopia in Singaporean-Chinese 15+ populations. AAPI patients face elevated POAG risk where myopia is a key driver. Anterior chamber assessment should be standard at every AAPI patient eye exam.

Farmworkers: 38% of US farmworkers report never having visited an eye care professional. Chronic UV exposure, foreign-body trauma, and pesticide exposure compound the need. Migrant Clinicians Network's Puntos de Vista program is the field's playbook for primary eye care delivered by community health workers — but mobile vision capacity to reach the population remains scarce.

Behind every percentage point is a person: a 65-year-old Salvadoran grandmother with undiagnosed glaucoma walking out the door without a referral; a 9-year-old kid who failed his school vision screening 18 months ago and still doesn't have glasses; a Watsonville strawberry harvester whose pterygium is now obscuring his vision but whose nearest FQHC vision clinic is a 90-minute drive each way.

Success stories: what's working

The FQHCs that have launched vision care are not the ones running pilots. They are running production. Five California FQHCs (and one Alabama benchmark) define what works — and the rest of the sector should treat them as case studies, not exceptions. See the full case study collection.

• Family Health Centers of San Diego (FHCSD) — 5 dedicated vision clinics, one of the largest FQHC vision program footprints in the US. Full-service: routine exams, dilated exams, glasses, contacts, glaucoma & DR screening. Flagship at Logan Heights co-located with pharmacy + dental + urgent care. Bilingual (English/Spanish) standard across all sites. Demonstrates that the typical 'FQHC vision is one site' assumption is a ceiling FQHCs put on themselves, not a structural limit.
• North East Medical Services (NEMS) — 5 sites across SF / Daly City / San Jose with an in-house ophthalmologist. The largest AAPI-serving FQHC vision program in California. Multi-language capacity (Cantonese, Mandarin, Vietnamese, Tagalog) addresses the LALES-equivalent disparity story for AAPI populations: elevated angle-closure glaucoma + myopia risk that demands routine anterior chamber assessment most general FQHC vision programs don't deliver.
• Alliance Medical Center (Sonoma County) — the only confirmed CA FQHC operating a mobile vision van. Fully equipped: exams, screenings, eyewear fitting, education. Permanent optometry at 2 fixed sites (Healdsburg, Windsor). Aligned with CA SB 776 mobile optometric office registry effective Jan 1, 2026. Serves rural farmworker communities the fixed-clinic model can't reach. Top 20th percentile for quality among all 1,400 US FQHCs.
• San Ysidro Health (San Diego) — running the most rigorous CA FQHC AI vision RCT currently underway. DRES-POCAI (Diabetic Retinopathy Screening with Point-of-Care AI), 848 diabetic patients across 2 FQHC sites, EyeArt point-of-care AI integrated with the EHR. Funded by Gordon and Betty Moore Foundation + Kaiser Permanente AIM-HI. ClinicalTrials.gov NCT06721351. Trial protocol published in JAMA Network Open. Outcomes will inform NACHC, AOA, and CHCF policy on autonomous AI DR screening reimbursement and FQHC capital deployment priorities.
• Tarzana Treatment Centers (LA) — confirmed LumineticsCore deployment. The CA bookend to the Cahaba implementation case study.
• Cahaba Medical Care (Alabama, the national benchmark) — deployed LumineticsCore for autonomous diabetic retinopathy screening and detected previously-missed DR in MORE THAN 1-IN-4 patients screened. Documented in Digital Diagnostics white paper, ADA 2022 Abstract 69-OR, and Bibb Voice news coverage. Implementation playbook lessons: embed AI screening in the routine diabetes follow-up visit (not separate eye visit) so the patient is already in the building; train medical assistants on retinal imaging in 4 hours total (no specialty optometric certification required for image acquisition); build an electronic referral pathway for AI-positive patients only. Compliance jumps from ~40% (refer-out model with 60% no-show rate) to 80%+. The 1-in-4 detection rate is the canonical figure for FQHC AI vision business cases.

Failure stories: what's breaking

Successes get the headlines. Failures get the lessons. Three California examples — and one structural federal failure — show what happens when FQHC vision care doesn't work.

• Tiburcio Vasquez Health Center (Hayward) — optometry 'closed until further notice' as of mid-2026. TVHC is a flagship Alameda County FQHC that visibly expanded vision care in recent years and is now offline. This is the leading indicator of workforce + reimbursement squeeze hitting smaller programs first. The lesson: a vision program without sustainable OD recruitment + Medi-Cal MCO billing infrastructure is fragile. The combination of $47 Medi-Cal reimbursement, NHSC ineligibility for ODs, and managed-care vision sub-vendor reshuffling (Alameda Alliance moved March Vision → VSP effective Jan 1, 2026) creates the operational fragility that drove TVHC's program offline.
• Borrego Health (San Diego County, defunct) — filed Chapter 11 in September 2022. DAP Health acquired the system through bankruptcy court in March 2023, with HRSA finalization in August 2023. Programs and services 'remain the same everywhere, in many cases improved' per DAP statements. But the bankruptcy was a near-miss — patient access could have collapsed. The lesson: FQHC vision care is sensitive to the financial health of its parent organization. When the FQHC goes through bankruptcy or scope-of-services change, vision is among the first programs at risk because it's not a HRSA-mandatory primary service.
• AB 2236 vetoed (September 2022) — would have authorized California optometrists to perform therapeutic laser procedures (SLT, peripheral iridotomy, posterior capsulotomy), lesion removal, and corneal crosslinking. Governor Newsom vetoed it, citing insufficient training duration vs ophthalmology residency. The lesson: California has one of the broadest non-surgical OD scopes nationally (post AB 407 + SB 1406) but the surgical-scope ceiling is real. FQHCs that treat OD scope expansion as 'unlimited' are setting up against a regulatory wall. Build referral relationships with ophthalmology partners now.
• NHSC optometry exclusion (structural federal failure) — Optometry was historically NHSC-eligible but was removed; the FY2026 NHSC LRP guidance confirms ODs remain ineligible. The American Optometric Association has been actively lobbying via the NHSC Improvement Act (HR 920 / S. 1445) for years without success. This is the single largest federal workforce policy headwind for FQHC vision care. Dental and primary care providers can pursue $50,000 in tax-free loan repayment for 2-year service. ODs cannot. Until this is fixed, FQHC OD recruitment will continue competing with private optometry without the NHSC hook that boosts dental and primary care recruitment. The financial ripple effect: TVHC closures.

Cases in motion right now

Three CA-relevant vision care storylines are actively unfolding in 2026. Each has implications for FQHC executives planning launch or expansion this year.

• DRES-POCAI RCT at San Ysidro Health (San Diego, in progress) — 848 diabetic patients across 2 FQHC sites, EyeArt point-of-care AI integrated with the EHR. Primary outcome: DR screening completion at 90 days. Funded by Gordon and Betty Moore Foundation + Kaiser Permanente AIM-HI. ClinicalTrials.gov NCT06721351. Trial protocol published in JAMA Network Open. This trial will produce the first methodologically rigorous CA FQHC-specific AI DR screening evidence base. Planned readouts will likely shape DHCS policy and Medi-Cal MCO contract requirements over the next 18 months. FQHC executives should treat this as the trial whose outcomes will define which AI vendor gets the most favored access at CA FQHCs.
• Vision To Learn + Warby Parker Pupils Project — 75 California school districts in 2025 (the largest school-vision footprint in the state). Vision To Learn operates 9 mobile clinics serving 800+ campuses statewide. 55,000+ LAUSD eye exams + 44,000 glasses since 2017. They are NOT competing with FQHCs — they are building the pediatric referral pipeline that FQHCs need to capture. The case in motion: which FQHCs will be first to sign formal MOUs that handle the medical follow-up Vision To Learn can't (strabismus, amblyopia, suspected glaucoma, congenital eye disease, pediatric diabetes complications). The MOU template is in our workplace guides — FQHCs that move first will own the pipeline.
• AltaMed AI scribe deployment (Los Angeles) — confirmed Abridge ambient AI scribe deployment across 600+ providers. Not vision-specific yet, but AltaMed already has on-site vision at multiple LA + OC sites and PACE-based specialty vision for the elderly. The next phase: extending ambient AI documentation to vision-specific workflows (refraction notes, retinal imaging interpretation handoff, glaucoma management documentation). AltaMed's progression from Abridge → vision-AI integration will likely be the most-watched CA FQHC AI vision story in late 2026.
• Lions Eye Foundation of CA-NV (San Francisco) — operating from 711 Van Ness Ave, providing free comprehensive ophthalmic care including cataract surgery for uninsured patients referred by clinics. The most actionable tertiary-care safety valve for Bay Area FQHCs that need to refer cataract, retinal, or surgical glaucoma cases. The case in motion: CA FQHCs that haven't yet established formal Lions Eye Foundation referral protocols should do so this quarter. The capacity is there; the FQHC pull-through is the gap.

Three deadlines on your calendar

Healthcare strategy is also calendar management. Three vision-relevant deadlines define the next 18 months of FQHC vision care decisions.

• California SB 776 mobile optometric office registry — EFFECTIVE Jan 1, 2026 (already live). Establishes a formal regulatory framework for compliant mobile vision operations. FQHCs operating or planning a mobile vision program (Alliance Medical Center is the only confirmed CA FQHC operating one currently) need to register with the CA Board of Optometry. Combined with AEYE-DS (the only FDA-cleared portable handheld autonomous AI for DR screening, expanded May 2024) and CA AB 407 expanded scope, this opens the operational pathway for any CA FQHC to launch a mobile vision program serving farmworker, school-based, and homebound populations.
• VSP Eyes of Hope 2027 booking — opens July 2026. 2026 mobile clinic schedules are largely full. Any CA FQHC that wants to host a VSP Eyes of Hope mobile vision clinic in 2027 should submit the request form when booking opens. VSP is CA-headquartered (Rancho Cordova), serves 200,000+ Californians lifetime, and is the most operationally ready charitable vision partner for FQHCs. The booking window is competitive.
• NHSC Improvement Act (HR 920 / S. 1445) — IN COMMITTEE indefinitely. The American Optometric Association has been lobbying for restoration of OD eligibility to NHSC Loan Repayment for years. Adding optometry back to NHSC eligible disciplines is the single largest federal workforce policy lever for FQHC vision care expansion. There is no statutory deadline — the deadline is whatever pressure FQHC executives, AOA, and constituent voices can put on House and Senate committees this session. Every FQHC with vision care is a constituent voice that can move this legislation. Push the policy fix from our advocacy tracker.
• California Medi-Cal optometry rate update — STALLED but advocacy active. The $47 per comprehensive eye exam rate has been unchanged for 25 years. CalMatters' April 2026 investigation re-elevated the issue. The California Optometric Association, CHCF, and FQHC coalition voices have been documenting the access crisis. DHCS rate-setting is under budget pressure from H.R. 1 cuts but the equity story (kids losing access to glasses) is powerful. FQHCs with vision programs have credibility in this conversation. Your data — encounter volumes, screening completion rates, missed-DR detection rates — is the case study DHCS needs.

What this all means for FQHC executives this quarter

If you're an FQHC CEO or CFO who hasn't yet had the 'should we launch vision care?' conversation, the data above suggests you're behind. The economics work. The AI is FDA-cleared and reimbursed favorably. The success stories are documented. The failure stories are warnings about workforce + financial fragility — not arguments against entering. The cases in motion will mostly resolve in favor of FQHCs that started early.

The two structural barriers (NHSC ineligibility for ODs, vision non-mandatory under Section 330) are real but navigable: capital must come from expansion grants, 340B savings, or operating capital, and OD recruitment must rely on mission, FTCA coverage, AB 407 scope expansion, and total compensation framing rather than the NHSC hook.

California's 220 FQHCs collectively serve the largest Medi-Cal population in the country. The 26% national figure for FQHC vision adoption suggests CA could be the leading-edge state — or it could continue letting Vision To Learn carry the pediatric load while structural failure cases (TVHC) repeat. The decision is being made one FQHC at a time, this quarter and next.

The 1-in-4 missed-DR detection rate at Cahaba Medical Care is the single most actionable statistic in this entire briefing. For an FQHC with a 1,000+ diabetic patient panel, deploying autonomous AI surfaces ~250 cases of vision-threatening pathology that would otherwise be missed. That's 250 patients walking out of your primary care clinic for diabetes management with progressing eye disease no one caught. Many will eventually go blind. Some already have. AI DR screening is the single most ROI-positive clinical AI investment available to any FQHC in 2026 — by a significant margin.

Run your numbers. Engage the FDA-cleared AI vendors. Sign the school-FQHC MOU. Push your representatives on HR 920 / S. 1445. Document outcomes for the federal and state policy fight. The first FDA-authorized AI in medicine was for eyes 8 years ago. Every quarter your FQHC waits is a quarter of preventable patient harm and forgone PPS revenue. Go.